sorafenib has been researched along with sulforaphane in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (sulforaphane) | Trials (sulforaphane) | Recent Studies (post-2010) (sulforaphane) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,754 | 65 | 1,317 |
| Protein | Taxonomy | sorafenib (IC50) | sulforaphane (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 9 | |
| Macrophage migration inhibitory factor | Homo sapiens (human) | 2.2 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, B; Büchler, MW; Gladkich, J; Herr, I; Kallifatidis, G; Liu, L; Mattern, J; Rausch, V; Salnikov, AV; Schemmer, P; Wirth, T; Zöller, M | 1 |
1 other study(ies) available for sorafenib and sulforaphane
| Article | Year |
|---|---|
Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Proliferation; Cells, Cultured; Colony-Forming Units Assay; Drug Synergism; Electrophoretic Mobility Shift Assay; Female; Fibroblasts; Humans; Immunoblotting; Immunoenzyme Techniques; Isoenzymes; Isothiocyanates; Luciferases; Mice; Mice, Nude; Neoplastic Stem Cells; Neovascularization, Pathologic; NF-kappa B; Niacinamide; Pancreatic Neoplasms; Phenylurea Compounds; Pyridines; Retinal Dehydrogenase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Sorafenib; Spheroids, Cellular; Sulfoxides; Thiocyanates; Xenograft Model Antitumor Assays | 2010 |